Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
1.600
-0.030 (-1.84%)
At close: Oct 30, 2026, 4:00 PM EST
1.481
-0.119 (-7.44%)
Pre-market: Nov 2, 2026, 5:29 AM EST
Nexalin Technology Market Cap
Nexalin Technology has a market cap or net worth of $1.33 million as of October 30, 2026. It is the 48,924th most valuable company in the world and the 6,602nd biggest in the United States. Its market cap has decreased by 95.08% in one year.
Market Cap
1.33M
Enterprise Value
322.08K
1-Year Change
-95.08%
Global Rank
Country Rank
#6,602 United States
Category
ChartMarket Cap Chart
Since the IPO on September 16, 2022, Nexalin Technology's market cap has decreased from $16.38M to $1.33M, a decrease of -91.90%. That is a compound annual growth rate of -45.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.33M | -87.25% |
| Dec 31, 2025 | 10.41M | -70.68% |
| Dec 31, 2024 | 35.50M | 1,079.21% |
| Dec 29, 2023 | 3.01M | -44.79% |
| Dec 30, 2022 | 5.45M | -66.71% |
| Sep 16, 2022 | 16.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| VolitionRx | 2.77M |
| 20/20 Biolabs | 2.72M |
| Phaos Technology Holdings (Cayman) Limited | 2.65M |
| Bluejay Diagnostics | 2.49M |
| WORK Medical Technology Group LTD | 2.42M |
| Nuwellis | 2.30M |
| Vivos Therapeutics | 2.29M |
| INVO Fertility | 2.28M |